Purpose: The aim of this study is to evaluate the detectability of hepatocellular carcinoma (HCC) in the explanted cirrhotic liver using gadoxetic acid-enhanced magnetic resonance imaging (Gd-EOB-MRI) and the degree of organic anion transporter OATP2/OATP8 (OATP1B1/1B3) HCC which could not be preoperatively detected by multi-detector computed tomography (MD-CT) and Gd-EOB-MRI. Methods: Eleven patients (HBV 3, HCV 7, nonBnonC 1) out of 145 recipients of liver transplantation were analyzed. The detectability by each imaging modality and the expression of OATP2/OATP8 of HCC were analyzed using the whole liver thin sliced histological and immunohistochemical examination retrospectively. Results: The imaging examination detected 17 lesions of HC...
In the United States, cirrhotic patients with known or suspected hepatocellular carcinoma (HCC) are ...
The purpose of this study was to retrospectively evaluate the diagnostic performance of dynamic gado...
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and liver transplantatio...
To evaluate the diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast a...
The incidence of hepatocellular carcinomas (HCCs) has increased worldwide in line with an improved s...
PURPOSE: To investigate the factors associated with hepatobiliary phase (HBP) enhancement at gadox...
We describe an 8-mm hepatocellular carcinoma (HCC) with hepatitis C virus-related cirrhosis in a 74-...
The aim of this study was to evaluate the histologic diagnosis of hypovascular hepatic lesions showi...
Early detection of small hepatocellular carcinoma (HCC) lesions can improve longterm patient surviva...
BACKGROUND/AIMS: The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made ...
none7noBackground: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnet...
Hepatobiliary phase (HBP) Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) has increased the ac...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
Hepatobiliary phase (HBP) Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) has increased the ac...
In the United States, cirrhotic patients with known or suspected hepatocellular carcinoma (HCC) are ...
The purpose of this study was to retrospectively evaluate the diagnostic performance of dynamic gado...
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and liver transplantatio...
To evaluate the diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast a...
The incidence of hepatocellular carcinomas (HCCs) has increased worldwide in line with an improved s...
PURPOSE: To investigate the factors associated with hepatobiliary phase (HBP) enhancement at gadox...
We describe an 8-mm hepatocellular carcinoma (HCC) with hepatitis C virus-related cirrhosis in a 74-...
The aim of this study was to evaluate the histologic diagnosis of hypovascular hepatic lesions showi...
Early detection of small hepatocellular carcinoma (HCC) lesions can improve longterm patient surviva...
BACKGROUND/AIMS: The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made ...
none7noBackground: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnet...
Hepatobiliary phase (HBP) Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) has increased the ac...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
Hepatobiliary phase (HBP) Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) has increased the ac...
In the United States, cirrhotic patients with known or suspected hepatocellular carcinoma (HCC) are ...
The purpose of this study was to retrospectively evaluate the diagnostic performance of dynamic gado...
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and liver transplantatio...